Pai Life Sciences Inc
Dba Pai Life Sciences Inc
CAGE Code: 47SX4
NCAGE Code: 47SX4
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 148051621
Summary
Pai Life Sciences Inc, Dba Pai Life Sciences Inc is an Active Commercial Supplier with the Cage Code 47SX4 and is tracked by Dun & Bradstreet under DUNS Number 148051621..
Address
1551 Eastlake Ave E Ste 250
Seattle WA 98102-7402
United States
Points of Contact
Related Information
People who viewed this 'CAGE Code' also viewed...
Micro Quill Software Publishing Inc University Of Washington Nursing Washington Packaging Supply, Inc. Energetic Music Inc Cossie Construction Co Nordine Mfg Co Archer Blower And Pipe Co Amplicom Computer Inc Dba Aci Micro Universal Colors Painting Co Environmental Review Ener-G-Foods Inc Bernth And Co Asi Sign Systems Smithkline Beecham Clinical Cascade Interactive Designs Inc Frank And Rosen University Plaza Hotel Darvin Electric Inc Whitestone Research Publications Prineas Stacy N Co
Frequently Asked Questions (FAQ) for CAGE 47SX4
- What is CAGE Code 47SX4?
- 47SX4 is the unique identifier used by NATO Organizations to reference the physical entity known as Pai Life Sciences Inc Dba Pai Life Sciences Inc located at 1551 Eastlake Ave E Ste 250, Seattle WA 98102-7402, United States.
- Who is CAGE Code 47SX4?
- 47SX4 refers to Pai Life Sciences Inc Dba Pai Life Sciences Inc located at 1551 Eastlake Ave E Ste 250, Seattle WA 98102-7402, United States.
- Where is CAGE Code 47SX4 Located?
- CAGE Code 47SX4 is located in Seattle, WA, USA.
Contracting History for CAGE 47SX4 Most Recent 25 Records
- 75N93022C00004
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- 14 Sep 2022
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $597,953.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00004
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- 14 Sep 2022
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $597,953.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00004
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- 25 Feb 2022
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $597,953.00
- Department Of Health And Human Services (Hhs)
- 75N93022C00004
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- 7 Jan 2022
- Late Stage Adjuvant Mimics Based On Tlr4 Agonists
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $597,953.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00028
- Development Of A Prophylactic Onchocerciasis Vaccine
- 3 Nov 2022
- Development Of A Prophylactic Onchocerciasis Vaccine
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $2,961,685.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00028
- Development Of A Prophylactic Onchocerciasis Vaccine
- 8 Sep 2023
- Development Of A Prophylactic Onchocerciasis Vaccine
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $2,961,685.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00028
- Development Of A Prophylactic Onchocerciasis Vaccine
- 14 Feb 2023
- Development Of A Prophylactic Onchocerciasis Vaccine
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $2,961,685.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00028
- Phase Ii - Development Of A Prophylactic Onchocerciasis Vaccine
- 16 Sep 2019
- Phase Ii - Development Of A Prophylactic Onchocerciasis Vaccine
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $2,961,685.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00028
- Eo14042 - Development Of A Prophylactic Onchocerciasis Vaccine
- 13 Oct 2021
- Eo14042 - Development Of A Prophylactic Onchocerciasis Vaccine
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $2,961,685.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00028
- Development Of A Prophylactic Onchocerciasis Vaccine
- 2 Dec 2021
- Development Of A Prophylactic Onchocerciasis Vaccine
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $2,961,685.00
- Department Of Health And Human Services (Hhs)
- 75N93019C00008
- The Objective Of This Contract Is To Develop Preclinical Rabbit Immunogenicity Data Demonstrating Efficacy Of The Selfadjuvantingand Self-Amplifying Rna Platform.
- 29 May 2019
- The Objective Of This Contract Is To Develop Preclinical Rabbit Immunogenicity Data Demonstrating Efficacy Of The Selfadjuvantingand Self-Amplifying Rna Platform.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $299,184.00
- Department Of Health And Human Services (Hhs)